The supportive care business developing products for all of us and international markets.

Amisulpride can be being produced by Acacia Pharma as APD403 for the prevention of chemotherapy induced nausea & vomiting .. Acacia Pharma starts APD421 Phase 3 research in combination with standard anti-emetics for PONV Acacia Pharma Ltd , the supportive care business developing products for all of us and international markets, announces the initiation of a Stage 3 study investigating APD421 in conjunction with standard anti-emetics, in preventing post-operative nausea & vomiting in high-risk patients.During treatment with class IC agents, supplementary usage of a beta-blocker, a calcium-channel blocker, or digoxin was suggested. Combinations of course IC and class III agents were not allowed. An aggressive rhythm-control strategy, by using direct-current cardioversion and trial of most appropriate antiarrhythmic drugs clinically, was recommended for any individual with recurrent atrial fibrillation. If antiarrhythmic drug therapy failed, supplementary ablation of atrial fibrillation was offered as indicated clinically. Follow-up Clinical follow-up and a 7-day Holter-monitor recording were planned at 3, 6, 12, 18, and 24 months. All the Holter recordings were analyzed at Aarhus University Medical center by the same experienced specialist; Holter analysis was blinded regarding treatment and randomization.16 Patients were also instructed to get hold of the study center if they had palpitations or other symptoms between your follow-up visits.